Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arti Easwar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Life (Basel, Switzerland)|November 27, 2021
Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory TestingArti Easwar, Alexa J Siddon
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2018
Apixaban Causing Leukocytoclastic VasculitisUsama Bin Nasir, Aswini Kumar, Arti Easwar
International Urogynecology Journal|November 28, 2018
Aggressive angiomyxoma presenting as posterior vaginal prolapseSarah S Boyd, Arti Easwar, Adam C Steinberg
Cancer Reports (Hoboken, N.J.)|October 23, 2023
Durable and dramatic response to checkpoint inhibition combined with COX-2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case studyJonathan Q Trinh, Cassaundra Acosta, Arti Easwar, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Life (Basel, Switzerland)|November 27, 2021
Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory TestingArti Easwar, Alexa J Siddon
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2018
Apixaban Causing Leukocytoclastic VasculitisUsama Bin Nasir, Aswini Kumar, Arti Easwar
International Urogynecology Journal|November 28, 2018
Aggressive angiomyxoma presenting as posterior vaginal prolapseSarah S Boyd, Arti Easwar, Adam C Steinberg
Cancer Reports (Hoboken, N.J.)|October 23, 2023
Durable and dramatic response to checkpoint inhibition combined with COX-2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case studyJonathan Q Trinh, Cassaundra Acosta, Arti Easwar, et al.
Pageof 1